Intermediate Clinical Events, Surrogate Markers and Survival

  • Myrto Lefkopoulou
  • Marvin Zelen


This paper investigates one- and two-sample problems comparing survival times when an individual may experience an intermediate event prior to death or reaching some well defined endpoint. The intermediate event may be polychotomous. Patients experiencing the intermediate event may have an altered survival distribution after the intermediate event. Score tests are derived for testing if the occurrence of the intermediate event actually alters survival. These models have implications for evaluating therapies without randomization as well as strengthening the log rank test for comparing two survival distributions. The exact distribution of the score tests can be found by conditioning on both the waiting time and occurrence of the intermediate event.


Score Test Survival Distribution Intermediate Event Asymptotic Procedure Tional Hazard Model 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Agresti, A. (1990) Categorical Data Analysis. New York: Wiley.zbMATHGoogle Scholar
  2. Aitken M, Laird N, Francis B. (1983) A reanalysis of the Stanford heart transplant data. J Am Stat Assoc 78: 264–274.CrossRefGoogle Scholar
  3. Andersen PK. (1986) Time dependent covariates and Markov processes. In Moolgavkar S, Prentice RL (eds.) Modern Statistical Methods in Chronic Disease Epidemiology. New York: Wiley, pp. 82–103.Google Scholar
  4. Andersen PK, Gill RD. (1982) Cox’s regression model for counting processes: A large sample study. Amer Stat 12: 730–736.Google Scholar
  5. Anderson JR, Cain KC, Gelber RD. (1983) Analysis of survival by tumor response. J Clin Oncol 1: 710–719.Google Scholar
  6. Crowley J, Hu M. (1977) Covariance analysis of heart transplant survival data. J Am Stat Assoc 72: 27–35.CrossRefGoogle Scholar
  7. Gray, Robert J. (1994) A kernel method for incorporating information on disease progression in the analysis of survival. Biometrika 81: 527–539.MathSciNetzbMATHCrossRefGoogle Scholar
  8. Hsieh FY, Crowley J, Tormey DC. (1983) Some test statistics for use in multistate survival analysis. Biometrika 70: 111–119.MathSciNetzbMATHCrossRefGoogle Scholar
  9. Mantel N, Byar DP. (1974) Evaluation of responsetime data involving transient states: An illustration using hearttransplant data. J Am Stat Assoc 69: 81–86.zbMATHCrossRefGoogle Scholar
  10. Turnbull BW, Brown BW, Hu M. (1974) Survivorship analysis of heart transplant data. J Am Stat Assoc 69: 74–80.CrossRefGoogle Scholar
  11. Weiss GH, Zelen M. (1963) A stochastic model for the interpretation of clinical trials. Proc Natl Acad Sci 50: 988–994.MathSciNetzbMATHCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1996

Authors and Affiliations

  • Myrto Lefkopoulou
    • 1
    • 2
  • Marvin Zelen
    • 1
    • 2
  1. 1.Dana-Farber Cancer InstituteHarvard School of Public HealthUSA
  2. 2.Biostatistics DepartmentHarvard School of Public HealthBostonUSA

Personalised recommendations